Weight loss drugs are changing the game, Eli Lilly exec says — but many still can't get themByBruce GilPublishedJanuary 2, 2025
Doctors are noticing an uptick in vaccine hesitancy, survey findsByBruce GilPublishedDecember 27, 2024
Bird flu mutations in the US's first severe H5N1 case may boost the virus's ability to infect humansByBruce GilPublishedDecember 27, 2024
FDA elevates Costco's quarter-million egg recall to its highest risk levelByBruce GilPublishedDecember 26, 2024
The FDA just approved Eli Lilly's Zepbound for sleep apnea — and Medicare coverage could be nextByBruce GilPublishedDecember 20, 2024
A next-gen Ozempic falls short in a drug trial — and Novo Nordisk stock plunges 20%ByBruce GilUpdatedDecember 20, 2024
Ozempic lures people to the doctor, Nestle's GLP-1 'shot,' an FDA Zepbound ruling: Pharma news roundupByBruce GilPublishedDecember 20, 2024
A millionaire tech 'biohacker' is microdosing Zepbound to stay youngByBruce GilUpdatedDecember 19, 2024
David Zaslav just sold $30 million worth of Warner Bros. Discovery stockByBruce GilUpdatedDecember 19, 2024
The FDA says the Zepbound shortage is over. That's rattling the weight loss industryByBruce GilUpdatedDecember 19, 2024
How to survive the holidays while you're on Ozempic or other weight loss drugsByBruce GilPublishedDecember 19, 2024
Nestle just launched a protein shot for weight loss that helps promote GLP-1 productionByBruce GilPublishedDecember 18, 2024
The USDA is finally trying to do something about the listeria outbreaksByBruce GilUpdatedDecember 18, 2024
Weight loss drugs are getting people to the doctor. Now comes the wave of long-ignored diagnosesByBruce GilPublishedDecember 17, 2024
